Scrip Regulatory Affairs
Eucomed calls for stricter regulatory control for medtech and pinpoints where it is needed
24 November 2011
Amanda Maxwell
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- EU medtech regulatory reform could involve unannounced notified body visits, greater transparency and tighter controls on Class III devices
- Calls for delay of EU medtech labelling decision as concerns continue
- April brings in new French healthcare laws: update on the implementing rules
- European Commission to propose leading role in new regulatory future for its expert devices group?
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
